Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG)

Authors
Category Primary study
JournalCancer Research
Year 2021
This article has no abstract
Epistemonikos ID: d8bc976b780b0e7099565baf69451f583a432cef
First added on: Feb 13, 2025